Monday, October 26, 2026 · Daily editionET --:--:--

Finished

ZEPU-AI5 Strength Training Study (ZEPUAI5RCT)

NCT07735702 · Bangladesh Medical University · Updated 22 Sept 2026

What is being tested
Robotic lower-limb gait training (ZEPU-AI5); Standard-of-care rehabilitation (conventional physiotherapy)
For
Stroke; Incomplete Spinal Cord Injury; Gait Impairment Following Orthopedic Surgery
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 60 years. About 51 people. The full rules are on the registry page.
Where
Bangladesh
When
Starts or started 14 May 2026, ends 12 Sept 2026. Registered 30 July 2026.
Results
None posted yet.

In the researchers' words

The goal of this clinical trial is to learn if robot-assisted lower-limb strength and gait training can improve safety, feasibility, and functional recovery in adults aged 18-60 years with lower-limb motor dysfunction due to stroke, incomplete spinal cord injury, or persistent gait impairment following orthopedic surgery. The main questions it aims to answer are: Is robot-assisted training using the ZEPU-AI5 device safe and well-tolerated, with an acceptable rate of device-related adverse events? Does adding ZEPU-AI5-assisted training to standard-of-care rehabilitation improve functional outcomes (such as walking distance, muscle strength, balance, and mobility) compared to standard-of-care rehabilitation alone? Researchers will compare an intervention group receiving standard-of-care rehabilitation combined with ZEPU-AI5-assisted training to a control group receiving standard-of-care rehabilitation alone, to see if the addition of robotic training leads to greater improvements in safety, functional recovery, and quality of life. Participants will: Undergo a baseline assessment before starting the study Receive either robot-assisted training plus standard-of-care rehabilitation, or standard-of-care rehabilitation alone, three times per week for 12 weeks Complete follow-up assessments every two weeks to evaluate safety, functional outcomes, and durability of any benefits
ClinicalTrials.gov, NCT07735702

Sites

  • Bangladesh Medical UniversityDhaka, Bangladesh